Truist Securities Maintains Buy on Merck & Co, Raises Price Target to $106

Truist Securities analyst Robyn Karnauskas maintains Merck & Co (NYSE:MRK) with a Buy and raises the price target from $103 to $106.

Truist Securities analyst Robyn Karnauskas maintains Merck & Co (NYSE:MRK) with a Buy and raises the price target from $103 to $106.

Total
0
Shares
Related Posts